Expertise in
18
conditions

Dr. Dr Nancy

Transplant Surgery
Digestive Diseases Consultants Of Kankakee SC
1615 N Convent St Ste 1, 
Bourbonnais, IL 
Offers Telehealth
27 Years of Experience
Expertise in
18
conditions
Digestive Diseases Consultants Of Kankakee SC
1615 N Convent St Ste 1, 
Bourbonnais, IL 

Overview

Dr Nancy is a Transplant Surgeon practicing medicine in Bourbonnais, Illinois. She has been practicing medicine for over 27 years.

Dr. Nancy is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Hepatitis C, Hepatitis, Autoimmune Hepatitis, Non-Alcoholic Fatty Liver Disease, and Liver Transplant.

She is actively involved in clinical research, co-authoring 112 peer reviewed articles and participating in 6 clinical trials.

Specialties

Transplant Surgery

Licenses

Internal Medicine in IL

Hospital Affiliations

Silver Cross Hospital And Medical Centers
Riverside Medical Center
Iroquois Memorial Hospital
Rush University Medical Center
Presence St Marys Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Digestive Diseases Consultants of Kankakee SC
1615 N Convent St Ste 1, Bourbonnais, IL 60914
Other Locations
Womens Health Consultants SC
1890 Silver Cross Blvd Ste 215, New Lenox, IL 60451

Additional Areas of Focus

Dr. Nancy has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
Enrollment Status: Terminated
Publish Date: September 17, 2025
Intervention Type: Other
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Enrollment Status: Unknown
Publish Date: August 25, 2023
Intervention Type: Drug
Study Drug: Peginterferon Lambda-1a
Study Phase: Phase 3
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
Enrollment Status: Completed
Publish Date: April 14, 2023
Intervention Type: Drug
Study Drugs: Lonafarnib, Ritonavir, PEG IFN-alfa-2a
Study Phase: Phase 3
A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects With Chronic Hepatitis C Previously Treated With an NS5A Inhibitor + Sofosbuvir Therapy
A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects With Chronic Hepatitis C Previously Treated With an NS5A Inhibitor + Sofosbuvir Therapy
Enrollment Status: Completed
Publish Date: February 26, 2020
Intervention Type: Drug
Study Phase: Phase 3
The Patient-Reported Outcomes Project of HCV-TARGET (PROP UP)
The Patient-Reported Outcomes Project of HCV-TARGET (PROP UP)
Enrollment Status: Completed
Publish Date: September 16, 2019
View 5 Less Clinical Trials

112 Total Publications

Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir.
Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir.
Journal: Viruses
Published: December 01, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Dr Mary
Transplant Surgery
Expertise in
14
conditions
Dr. Dr Mary
Transplant Surgery
Referral may be required

Office

675 N Saint Clair St Ste 100, 
Chicago, IL 
 (30.9 miles away)
312-926-4525
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr Mary is a Transplant Surgeon practicing medicine in Chicago, Illinois. Dr. Mary is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Cirrhosis, Liver Transplant, and Endoscopy.

Expertise in
14
conditions
Dr. Daniel R. Ganger
Transplant Surgery
Expertise in
14
conditions
Dr. Daniel R. Ganger
Transplant Surgery
Referral may be required
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (30.9 miles away)
312-695-4837
Experience:
49+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Ganger is a Transplant Surgeon practicing medicine in Chicago, Illinois. He has been practicing medicine for over 49 years. Dr. Ganger is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Cirrhosis, Liver Transplant, and Endoscopy. Dr. Ganger is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).

Expertise in
9
conditions
Dr. Dr Piotr
Transplant Surgery
Expertise in
9
conditions
Dr. Dr Piotr
Transplant Surgery
Referral may be required

University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (26.0 miles away)
773-702-4500
Languages Spoken:
English
See accepted insurances

Dr Piotr is a Transplant Surgeon practicing medicine in Chicago, Illinois. Dr. Piotr is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Hereditary Pancreatitis, Childhood Pancreatitis, Islet Cell Transplantation, and Pancreatectomy.

Frequently Asked Questions about Dr. Dr Nancy

How do I make an appointment with Dr. Dr Nancy?

You can book an appointment with Dr. Dr Nancy by calling their office at 815-937-5200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Dr Nancy a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dr Nancy is classified as an Elite expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Dr Nancy specialize in?

While Dr. Dr Nancy is a Transplant Surgery, they have specific expertise in Hepatitis C, Hepatitis, and Autoimmune Hepatitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.

Does Dr. Dr Nancy participate in research or clinical trials?

Yes. Dr. Dr Nancy has published 112 articles and abstracts on conditions like Hepatitis C. You can view a list of Dr. Dr Nancy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Dr Nancy accept my insurance?

Dr. Dr Nancy accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 815-937-5200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nancy's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile